Research Aims and Achievements

Rare case of Hunter syndrome in a girl

Hunter syndrome (mucopolysaccharidosis type II) is a recessive X-linked disorder due to mutations in the iduronate 2-sulfatase (IDS) gene encoding a lysosomal iduronate 2-sulfatase.
Read more

First Study of prevalence and risk factors for abdominal wall hernia in the Central Russian population

Medical history of 10 > years was taken and clinical examination was performed for residents of Kryukovo rural community (Central Russia). Abdominal wall hernias have been found in 20.9% of population, including 298 men and 485 women (mean age 49.3).
Read more

Study of natalizumab treatment of multiple sclerosis in Russia

Natalizumab (NTZ) is approved in Russia for the treatment of highly active relapsing remitting multiple sclerosis and is reimbursed via federal budget program.
Read more

Participation in randomised, open-label, phase 3 trial of the combination for treatment of multiple myeloma

Pirogov Medical University has took a part in the international randomised, open-label, phase 3 trial of the combination of pomalidomide, bortezomib, and dexamethasone for treatment of multiple myeloma.
Read more

Lecture “The Continuing Need for Useless Knowledge” of Prof. Martin Chalfie

On April 22, Nobel Prize Winner Professor Martin Chalfi of Columbia University (USA) held a lecture “The Continuing Need for Useless Knowledge” at our University. The famous scientist talked about how scientific discoveries are made, and how the...
Read more

Advance in the development of our database of T-cell receptors (TCR) with known specificity

VDJdb is a curated database of T-cell receptor (TCR) sequences with known antigen specificities.
Read more